Accessibility Statement

GENEQ Global is committed to ensuring digital accessibility for all users, regardless of ability, technology, or circumstance. We want as many people as possible to be able to use this website, and we aim to provide an inclusive experience that reflects our mission of equity in genomics and precision medicine.

This accessibility statement applies to the website: www.geneqglobal.com

Our commitment to accessibility

We strive to ensure that our website is accessible and usable for everyone. This means you should be able to:

• Zoom in up to 200% without difficulty

• Navigate the website using a keyboard

• Access content using screen readers and assistive technologies

• Read text with sufficient contrast and clear layout

• Understand content that is structured in a consistent, logical way

We aim to conform with the Web Content Accessibility Guidelines (WCAG) 2.2, at least to Level AA standards.

​

Accessibility standards and legal context

GENEQ Global recognises its responsibilities under:

• The Equality Act 2010

• The Public Sector Bodies (Websites and Mobile Applications) Accessibility Regulations 2018 (as best practice guidance)

• The international standard WCAG 2.2 Level AA

Although GeneQ Global is not classified as a public sector body, we follow these standards as part of our commitment to equity, inclusion, and ethical innovation.

​

How accessible is this website

We are continuously working to improve accessibility across our site. However, some parts of the website may not yet be fully accessible.

Known limitations may include:

• Some PDF or downloadable documents may not be fully accessible to screen reader software

• Occasional missing alternative text on decorative or older images

• Some colour contrast combinations may not meet WCAG standards in all areas

• Certain interactive elements may require further optimisation for keyboard navigation

We are actively addressing these issues as part of our ongoing development.

​

Feedback and contact information

​

We welcome feedback on the accessibility of GENEQ Global’s website. If you experience any barriers or require content in an alternative format, please contact us:

Email: info@geneqglobal.com

We aim to respond within 5 working days.

​

Requesting alternative formats

If you need information from this website in an alternative format (such as accessible PDF, large print, plain text, or audio), we will do our best to provide this.

Please email us with:

• The page or document you need

• The format you require

• Any assistive technology you are using

 

Reporting accessibility problems

We are committed to improving accessibility. If you find any issues not listed above, or believe we are not meeting accessibility requirements, please let us know so we can address them.

​

Compliance status

This website is currently partially compliant with the WCAG 2.2 AA standard, due to the known issues listed above.

We are undertaking improvements to increase compliance over time.

​

Ongoing improvements

GeneQ Global is taking the following steps to enhance accessibility:

• Conducting periodic accessibility audits

• Improving colour contrast and readability

• Ensuring all images have meaningful alternative text

• Optimising keyboard navigation and interactive elements

• Training content contributors on inclusive digital publishing practices

Accessibility is an integral part of our mission to make genomics and precision medicine more equitable worldwide.

 

Preparation of this statement

This statement was prepared on 28 January 2026.
It will be reviewed annually, or sooner if significant changes are made to the site.